Table 2.
Therapy change and timing
| Number (n) | Age (years) | |
|---|---|---|
| BB—> ARB | 6/16 | 13.5 ± 5.8 |
| BB—> BB + ARB—> ARB | 4/16 | 9.2 ± 1.8 10.2 ± 1.9 |
| BB—> BB + ARB | 1/16 | 16.6 |
| ARB—> BB + ARB | 5/16 | 8.5 ± 5.3 |
ARB angiotensin receptor blocker, BB beta blocker
Therapy change and timing
| Number (n) | Age (years) | |
|---|---|---|
| BB—> ARB | 6/16 | 13.5 ± 5.8 |
| BB—> BB + ARB—> ARB | 4/16 | 9.2 ± 1.8 10.2 ± 1.9 |
| BB—> BB + ARB | 1/16 | 16.6 |
| ARB—> BB + ARB | 5/16 | 8.5 ± 5.3 |
ARB angiotensin receptor blocker, BB beta blocker